Adhoc News

06.10.2025
Ad-hoc: Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
16.09.2025
Ad-hoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share
01.09.2025
Ad-hoc: Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
02.04.2025
Ad-hoc: Marinomed Biotech AG has been a victim of cybercrime
Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com